|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 113.88 USD | -2.61% |
|
-6.85% | +227.24% |
| 08-18 | Truist Adjusts Price Target on Corcept Therapeutics to $164 From $50, Maintains Buy Rating | MT |
| 07-29 | Corcept Therapeutics Incorporated, Q2 2026 Earnings Call, Jul 29, 2026 |
| Market Cap | 12.31B 10.61B 9.95B 9.08B 17.1B 1,177B 17.16B 118B 46.04B 594B 46.22B 45.21B 1,969B | P/E 2026 * |
55.3x | P/E 2027 * | 26.5x |
|---|---|---|---|---|---|
| Enterprise Value | 12.31B 10.61B 9.95B 9.08B 17.1B 1,177B 17.16B 118B 46.04B 594B 46.22B 45.21B 1,969B | EV / Sales 2026 * |
10.7x | EV / Sales 2027 * | 7.22x |
| Free-Float |
65.9% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Corcept Therapeutics Incorporated
| 1 day | -2.61% | ||
| 1 week | -6.85% | ||
| Current month | -0.53% | ||
| 1 month | +20.90% | ||
| 3 months | +66.54% | ||
| 6 months | +218.99% | ||
| Current year | +227.24% |
| 1 week | 112.97 |  | 126.38 |
| 1 month | 104.75 | | 126.38 |
| Current year | 28.66 | | 126.38 |
| 1 year | 28.66 | | 126.38 |
| 3 years | 20.84 | | 126.38 |
| 5 years | 15.82 | | 126.38 |
| 10 years | 5.24 | | 126.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
CEO | Chief Executive Officer | 68 | 1998-12-31 |
Atabak Mokari
DFI | Director of Finance/CFO | 49 | 2021-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 48 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
BRD | Director/Board Member | 68 | 1998-12-31 |
James Wilson
CHM | Chairman | 82 | 1998-12-31 |
David Mahoney
BRD | Director/Board Member | 71 | 2004-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/25/26 | Fiscal year | Executive/Senior Manager | 92,865 | 0.0859% | ||
| 8/18/26 | Sell | Director | -103,606 | 0.0958% | ||
| 8/17/26 | Don | Company Secretary | -10,125 | 0.0094% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.61% | -6.85% | +63.66% | +253.45% | 12.31B | |
| -0.13% | -6.44% | +60.47% | +112.05% | 1,047B | |
| +0.85% | -0.81% | +52.77% | +63.15% | 646B | |
| -1.03% | -3.58% | +22.87% | +73.29% | 451B | |
| -1.46% | -4.50% | +37.43% | +38.41% | 355B | |
| -0.72% | -2.89% | +21.86% | +36.79% | 291B | |
| -1.19% | -2.21% | +1.35% | +12.29% | 252B | |
| -1.05% | -1.57% | +51.40% | +68.55% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.29% | 203B | |
| -2.14% | -0.30% | +29.42% | +89.10% | 181B | |
| Average | -0.95% | -3.09% | +32.36% | +69.28% | 367.16B | |
| Weighted average by Cap. | -0.49% | -3.47% | +38.74% | +66.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.15B 988M 926M 845M 1.59B 110B 1.6B 10.99B 4.29B 55.3B 4.3B 4.21B 183B | 1.7B 1.47B 1.38B 1.26B 2.37B 163B 2.38B 16.34B 6.38B 82.25B 6.4B 6.26B 273B |
| Net income | 242M 208M 195M 178M 336M 23.09B 337M 2.32B 903M 11.65B 907M 887M 38.64B | 594M 512M 480M 438M 825M 56.73B 827M 5.69B 2.22B 28.64B 2.23B 2.18B 94.96B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | US$113.88 | -2.61% | 917,931 |
| 26-08-27 | US$116.93 | -2.40% | 642,409 |
| 26-08-26 | US$119.80 | -3.05% | 981,085 |
| 26-08-25 | US$123.57 | +0.27% | 981,693 |
| 26-08-24 | US$123.24 | +0.81% | 1,012,861 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CORT Stock
Select your edition
All financial news and data tailored to specific country editions
